Ulrich Dührsen

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

Eva Hoster, Martin Dreyling, Christian Gisselbrecht et al. · Blood · 2007 · 971 citations

Medicine, Hematology, Oncology +11

Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non–Germinal Center B-Cell Diffuse Large B-Cell Lymphoma

Anas Younes, Laurie H. Sehn, Peter Johnson et al. · Journal of Clinical Oncology · 2019 · 616 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients

Ulrich Dührsen, James Boyd, George Kannourakis et al. · Blood · 1988 · 593 citations

Medicine, Hematology, Oncology +16

Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria

Peter Hillmen, Petra Muus, Ulrich Dührsen et al. · Blood · 2007 · 578 citations · Full text

Medicine, Hematology, Pharmacology +11

Immunochemotherapy With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Significantly Improves Response and Time to Treatment Failure, But Not Long-Term Outcome in Patients With Previously Untreated Mantle Cell Lymphoma: Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG)

Georg Lenz, Martin Dreyling, Eva Hoster et al. · Journal of Clinical Oncology · 2005 · 573 citations · Full text

Medicine, Oncology, Pharmacotherapy +16